Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Allergy Therapeutics Fundamentals

Company Name Allergy Therapeutics Last Updated 28 May 2020
Industry Health Care Sector Pharmaceuticals
Shares in Issue (m) 636.17 Market Cap (£m) 68.39
PE Ratio 19.55 Div per Share () 0.00
Div Yield 0.00 Div Cover 0.00
EPS 0.55 EPS Growth (%) 143.31
PEG 0.14 DPS Growth (%) n/a
Debt Ratio 27.27 Debt Equity Ratio 0.46
Net Gearing 5.11 Gross Gearing 45.17
Asset Equity Ratio 1.82 Cash Equity Ratio 73.06
Quick Ratio 2.21 Current Ratio 2.77
Price To Book Value 1.82 ROCE 8.31

Allergy Therapeutics Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total

Allergy Therapeutics Company Financials

Assets (£m) 2019 2018 2017
Tangible Assets 11 10 10
Intangible Assets 5 5 5
Investments 6 5 5
Total Fixed Assets 22 20 20
Stocks 9 9 7
Debtors 10 7 8
Cash & Equivalents 27 16 22
Other Assets 0 0 0
Total Assets 69 51 57
Liabilities (£m) 2019 2018 2017
Creditors within 1 year 17 15 14
Creditors after 1 year 14 13 13
Other Liabilities 0 0 0
Total Liabilities 31 28 27
Net assets 38 23 30
Equity (£m) 2019 2018 2017
Called up share capital 1 1 1
Share Premium 113 102 102
Profit / Loss 4 -7 -2
Other Equity 44 42 41
Preference & Minorities 0 0 0
Total Capital Employed 38 23 30
Ratios 2019 2018 2017
Debt Ratio 27.27 36.69 30.58
Debt-to-Equity 0.46 0.48 0.49
Net Gearing 5.11 24.40 8.91
Gross Gearing 45.17 54.85 47.60
Assets / Equity 1.82 2.22 1.91
Cash / Equity 73.06 67.44 73.83
EPS 0.55 -1.27 -0.42
Cash Flow (£m) 2019 2018 2017
Cash from operating activities 6 -4 0
Cashflow before financing 2 -6 -2
Increase in Cash 12 -7 -2
Income (£m) 2019 2018 2017
Turnover 74 68 64
Cost of sales 18 17 17
Gross Profit 55 51 47
Operating Profit 4 -7 -2
Pre-Tax profit 4 -7 -2
Profit / Loss for the year 1 1 1

Allergy Therapeutics Company Background

Sector Pharmaceuticals
Activities Allergy Therapeutics plc is an international specialty pharmaceutical group focussed on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development. Formed in 1999 out of Smith Kline Beecham, Allergy Therapeutics is headquartered in Worthing, UK.
Latest Interim Date 04 Mar 2020
Latest Fiscal Year End Date 25 Sep 2019

Allergy Therapeutics Directors

Appointed Director Position
01 Sep 2009 Manuel Llobet Chief Executive Officer
09 Jun 2016 Nicolas Alexander Ulrich Wykeman Finance Director
30 Sep 2010 Peter Sinclair Jensen Non-Executive Chairman
19 Jun 2019 Mary Geraldine Tavener Non-Executive Director
08 Sep 2004 Stephen Rushworth Smith Non-Executive Director
06 Jun 2017 Dr Babatunde Adekunle Otulana Non-Executive Director
07 Nov 2018 Scott Michael Leinenweber Non-Executive Director

Allergy Therapeutics Contact Details

Company Name Allergy Therapeutics
Company Address Dominion Way, Worthing, West Sussex BN14 8SA.
Company Telephone +44 (0)1903 844 700
Company Website http://www.allergytherapeutics.com/

Allergy Therapeutics Advisors

Auditor Name Grant Thornton UK LLP
Auditor Address The Explorer Building, Fleming Way, Manor Royal, Gatwick RH10 9GT
Auditor Website http://www.grant-thornton.co.uk/
Auditor Telephone +44 (0)870 381 7000
Registrar Name Link Asset Services
Registrar Address The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU.
Registrar Website http://www.linkassetservices.com/
Registrar Telephone 0870 162 3100
Broker Name Panmure Gordon & Co
Broker Address One New Change, London EC4M 9AF.
Broker Website http://www.panmure.com/
Broker Telephone +44 (0)20 7886 2500
Adviser Name Panmure Gordon & Co
Adviser Address One New Change, London EC4M 9AF.
Adviser Website http://www.panmure.com/
Adviser Telephone +44 (0)20 7886 2500
Solicitor Name Berwin Leighton Paisner LLP
Solicitor Address Adelaide House, London Bridge, London EC4R 9HA.
Solicitor Website http://www.blplaw.com/
Solicitor Telephone +44 (0)20 7760 1000
Stockbroker Name n/a
Stockbroker Address n/a
Stockbroker Website n/a
Stockbroker Telephone n/a